The global eye care supplements market is expected to grow at a significant CAGR 6.3% during the forecast period (2022-2028).  The market is being driven by a growing senior population, increased exposure to blue light, and an increase in the prevalence of various vision problems such as macular degeneration, refractive errors, cataracts, inflammation, diabetic retinopathy, corneal opacity, trachoma, and dry eye syndrome. According to the World Health Organization, 2.2 billion individuals worldwide were affected by visual impairments or blindness in 2019, with 1 billion having moderate to severe distance vision impairment. Most of these vision impairments are due to uncorrected refractive errors (123.7 million) and cataract (65.2 million). Some other causes of visual impairment include glaucoma (6.9 million), unaddressed presbyopia (826 million), diabetic retinopathy (3 million), corneal opacity (4.2 million) and trachoma (2 million). Visual impairment may lead to various conditions such as accidents, depression and anxiety disorders. As a result, the demand for supplements for the prevention of various vision-related diseases has been significantly increased, which in turn, is contributing to the growth of the market during the forecast period.

The key companies operating in the global eye care supplements market are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launch, and product innovation to remain competitive in the marketplace. For instance, in June 2021, PharmaLinea launched a range of preventative eye health supplements in consumer-friendly packaging. The decision came as a result of the epidemic, which has increased screen time and linked to a surge in eye health concerns. Your Vision Orosticks and Your Vision Liquid Sticks are two new additions to PharmaLinea's portfolio of private label eye health products. Further, NovaBay Pharmaceuticals, Inc. announced the launch of NovaSight, an ocular health supplement, on Amazon.com in November 2019. VisiVite introduced two new supplements in January 2020 including VisiVite Blue Light Basher Formula, which replenishes the macular pigment layer and dissipates high-energy blue light, and VisiVite AREDS 2 Chewable Tablets, which provide maximal ocular nourishment.

Market Coverage

• The market number available for – 2021-2028

• Base year- 2021

• Forecast period- 2022-2028

• Segment Covered- 

o By Type 

o By Form 

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape:  Vitabiotics Ltd., Pfizer Inc., and Amway Corp., among others. 

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Eye Care Supplements Market Report by Segment

By Type 

• Lutein and Zeaxanthin

• Antioxidants

• Omega-3 Fatty acids

• Coenzyme Q10

• Others (Flavonoids, Alpha-Lipoic Acid) 

By Form 

• Tablets 

• Capsules

• Powder

• Other (Softgels) 

Global Eye Care Supplements Market Report by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa